REFERENCES
- Carpenter C C, Fischl M A, Hammer S M, Hirsch M S, Jacobson D M, Katzenstein D A, Montaner J SG, Richman D D, Saag M S, Schooley R T, Thompson M A, Vella S, Yeni P G, Volberding P A. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the international AIDS Society - USA panel. J Am Med Assoc 1997; 277: 1962–1969
- Deeks S G, Smith M, Holodniy M, Kahn J O. HIV-1 protease inhibitors: a review for clinicians. J Am Med Assoc 1997; 277: 145–153, [CROSSREF]
- Gulick R M, Mellors J W, Havlir D, Eron J J, Gonzalez C, McMahon D, Richman D D, Valentine F T, Jonas L J, Meibohm A, Emini E A, Chodakewitz J A. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734–739, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hogg R S, Heath K V, Yip B, Craib K J, O'Shaughnessy M V, Schechter M T, Montaner J S. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. J Am Med Assoc 1997; 279: 450–454, [CROSSREF]
- Mouton Y, Alfandari S, Valette M, Cartier F, Dellamonica P, Humbert G, Lang J M, Massip P, Mechali D, Leclercq P, Modai J, Portier H. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997; 11: F101–F105, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Furtado M R, Callaway D S, Phair J P, Kunstman K J, Stanton J L, Macken C A, Perelson A S, Wolinsky S M. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 1999; 340(21)1614–1622, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Natarajan V, Bosche M, Metcalf J A, Ward D J, Lane H C, Kovacs J A. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet 1999; 353(9147)119–120, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Geier S A, Libera S, Klauss V, Goebel F D. Sicca syndrome in patients infected with the human immunodeficiency virus. Ophthalmology 1995; 102(9)1319–1324, [PUBMED], [INFOTRIEVE], [CSA]
- Rutherford G W, Payne S F, Lemp G F. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Acquir Immune Defic Syndr 1990; 3(Suppl 1)S4–7, [PUBMED], [INFOTRIEVE]
- Haverkos H W, Friedmann-Kien A E, Drotman D P, Morgan W M. The changing incidence of Kaposi's sarcoma among patients with AIDS. J Am Acad Dermatol 1990; 22(6 Pt 2)1250–1253, [PUBMED], [INFOTRIEVE]
- Ghabial R, Quivey J M, Dunn J P, jr, Char D H. Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's sarcoma of the eyelids and conjunctiva. Arch Ophthalmol 1992; 110(10)1423–1426
- Jones J L, Hanson D L, Dworkin M S, Jaffe H W. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 24(3)270–274, [PUBMED], [INFOTRIEVE]
- Ragozzino M W, Melton L J, Kurland L T, Chu C P, Perry H O. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61(5)310–316, [PUBMED], [INFOTRIEVE]
- Veenstra J, Krol A, van Praag R M, Frissen P H, Schellekens P T, Lange J M, Coutinho R A, van der Meer J T. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995; 9(10)1153–1158, [PUBMED], [INFOTRIEVE]
- Glesby M J, Moore R D, Chaisson R E. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(2)370–375, [PUBMED], [INFOTRIEVE], [CSA]
- Jabs D A, Green W R, Fox R, Polk B F, Bartlett J G. Ocular manifestations of the acquired immunodeficiency syndrome. Ophthalmology 1989; 96: 1092–1099, [PUBMED], [INFOTRIEVE]
- Jacobson M A. Current management of cytomegalovirus disease in patients with AIDS. AIDS Res Hum Retrovir 1994; 10: 917–923, [PUBMED], [INFOTRIEVE], [CSA]
- Ries E, Muhlbauer B, Ruhswurm I, Krepler K, Derbolav A, Svolba G, Rieger A, Wedrich A. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy. Ophthalmologica 1998; 212(4)239–243, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kuppermann B D, Petty J G, Richmann D D, Mathews W C, Fullerton S C, Rickman L S, Freeman W R. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immune deficiency syndrome. Am J Ophthalmol 1993; 115: 575–582, [PUBMED], [INFOTRIEVE], [CSA]
- Holland G N, Sidikaro Y, Kreiger A E, Hardy D, Sakamoto M J, Frenkel L M, Winston D J, Gottlieb M S, Bryson Y J, Champlin R E, Ho W G, Winters R E, Wolfe P R, Cherry J D. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology 1987; 94: 815–823, [PUBMED], [INFOTRIEVE]
- Jacobson M A, O'Donell J J, Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother 1989; 33: 736–741, [PUBMED], [INFOTRIEVE], [CSA]
- Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. Ann Intern Med 1997; 126: 264–274, [CSA]
- Reed J B, Schwab I R, Gordon J, Morse L S. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997; 124: 199–205, [PUBMED], [INFOTRIEVE], [CSA]
- Ruhswurm I, Ries E, Krepler K, Derbolav A, Rieger A, Armbruster C, Wedrich A. Control of cytomegalovirus retinitis after combination antiretroviral therapy. Acta Ophthalmol Scand 1999; 77(4)471–473, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vrabec T, Baldassano V F, Whitcup S M. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 1998; 105: 1259–1264, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 1998; 177: 1080–1083, [PUBMED], [INFOTRIEVE]
- Jacobson M A, Zegans M, Pavan P R, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997; 349: 1443–1445, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Freeman W R, Chen A, Henderly D E, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989; 107: 229–235, [PUBMED], [INFOTRIEVE], [CSA]
- Holland G N, Pepose J S, Pettit T H, Gottlieb M S, Yee R D, Foos R Y. Acquired immunodeficiency syndrome: ocular manifestations. Ophthalmology 1983; 90: 859–873, [PUBMED], [INFOTRIEVE]
- Glasgow B J, Weisberger A K. A quantitative and cartographic study of retinal microvasculopathy in acquired immunodeficiency syndrome. Am J Ophthalmol 1994; 118: 46–56, [PUBMED], [INFOTRIEVE], [CSA]
- Doan S, Cochereau I, Guvenisik N, Diraison M C, Mousalatti H, Thanh H X. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol 1999; 128(2)250–251, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]